Clinical trial · Observational
Biomarker Feedback to Motivate Tobacco Cessation in Pregnant ALaska Native Women: Phase 2
NCT02018640CI-TRIAL-00030835MAW Phase 2completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Use of tobacco is very high among Alaska Native pregnant women. The investigators are conducting a three phase study. The first study is nearly completed and involved measuring biomarkers of tobacco exposure in mothers and infants. The second phase of the research is a qualitative study to translate the biomarker findings to an intervention.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Pregnancy | — | UNRESOLVED | — |
| Tobacco Use | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- receptivity to cancer risk messages
- timeFrame
- baseline
- description
- interview of participant reactions to biomarker findings
Secondary outcomes (1)
- measure
- confidant perceptions of cancer risk information
- timeFrame
- baseline
- description
- interview of family members, friends, relatives
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: To be eligible the woman must: 1. be Alaska Native 2. be aged 18 years of age or older 3. provide written informed consent 4. have participated in Phase 1 of the research or is currently pregnant (\<= 24 weeks gestation) 5. have used any tobacco product at least once in the past 7 days (cigarettes or both cigarettes/ST) To be eligible the confidant (he/she) must: 1. be referred by the woman participant 2. be aged 18 years of age or older 3. provide written informed consent Exclusion Criteria: 1\. does not provide written informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.